Home
> Our People
> General Director Message

General Director Message

2025.08.01

On behalf of Daiichi Sankyo Vietnam, I would like to convey our sincere appreciations to all our stakeholders for supporting Daiichi Sankyo and our staff in Viet Nam.

Viet Nam is rapidly growing not only in economy but also in the field of healthcare, with development of medical care through implementation of advanced medical services and treatment technology as well as nationwide telehealth system. Therefore, expectations for pharmaceutical industries are rising year by year to fulfill unmet medical needs.

Daiichi Sankyo is a global pharmaceutical company with more than 100 years of scientific expertise to discover and develop innovative pharmaceutical products. In Viet Nam, since our establishment, we have been focusing on delivering high-quality pharmaceutical products designed to meet the needs of Vietnamese.

As we look to the future, we remain dedicated to our mission of improving quality of life through our innovative healthcare solutions. Furthermore, we try to be a trusted medical partner with healthcare professionals by providing scientific information and supporting medical research and education.

Finally, I highly expect and believe that our challenges will be successful, and we do commit all our activities will keep high ethical standard.

Thank you again, and I wish you and your family every personal success and happiness.

Yukinori Tominaga

General Director

Daiichi Sankyo Vietnam Co., Ltd.

.

More Stories

Our Partners

CSR in Vietnam

Daiichi Sankyo Group Employee Code of Conduct

CEO Message: The Daiichi Sankyo Group is committed to realizing our 2025 Goal of being a “global pharma innovator with a competitive advantage in oncology,” and we are making significant strides towards reaching our 2030 Vision as an “innovative global healthcare company contributing to the sustainable development of society.”

Daiichi Sankyo Vietnam Partners with VinaCapital Foundation in the Heartbeat Vietnam Program – Bringing Healthy Heartbeats to Children

On March 26, 2025, at the VinaCapital Foundation (VCF) office – 14E21 Thao Dien, Thao Dien Ward, Thu Duc City, Ho Chi Minh City, Daiichi Sankyo Vietnam officially signed a sponsorship agreement to fund heart surgeries for children with congenital heart disease from underprivileged backgrounds. This marks a significant step in DSVN’s journey of contributing to the community and fulfilling its corporate social responsibility mission.

Terumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam

Terumo Vietnam Medical Equipment (Terumo Vietnam) and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam. The initiative aims to support healthcare professionals in updating their knowledge and skills in interventional cardiology.

Enhancing reproductive health knowledge for adolescents in the highland areas of Yen Bai

On March 12, Save the Children, in collaboration with Yen Bai’s health sector, organized a workshop to share the results of the project to improve reproductive and sexual health for adolescents in Yen Bai province.Dr. Tran Van Hien, Deputy Director of Yen Bai Obstetrics and Pediatrics Hospital, stated that the project's goal is to improve reproductive health for adolescents aged 15-19, with indirect beneficiaries including parents, grandparents, caregivers, healthcare workers, and teachers. The project is implemented over 20 months, from July 2023 to March 2025, in Mu Cang Chai and Van Chan districts.

Technical Cooperation for MR Vaccine Production in Vietnam

For five years until March 2018, Daiichi Sankyo Biotech Co., Ltd. (formerly, Kitasato Daiichi Sankyo Vaccine) cooperated with the Japan International Cooperation Agency (JICA) for the Vietnam POLYVAC* "Measles-Rubella (MR) Vaccine Production Technology Transfer Project."

This activity enabled Vietnam to produce safe and reliable MR vaccine in the country without relying on imported ones.
In March 2018, the Vietnam-made MR vaccine was incorporated into the Expanded Program on Immunization, and administration of the vaccine to children in Vietnam started. Recently, the MR vaccine was utilized during epidemics among people including adults.
This activity has been highly regarded in Vietnam, and earned the Vietnamese Minister of Health's "Certificate of Good Performance Award" in September 2017, which is the most prestigious award for achievements in Vietnamese healthcare.

Activity of “Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province” project in March

From March 12 to 14, 2024, a delegation of representatives of the Embassy of Japan in Vietnam, Daiichi Sankyo Group Japan, and Daiichi Sankyo Vietnam Co., Ltd visited Yen Bai province. The trip is part of the activities of the project "Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province " implemented by Save the Children.

On the first working day, the delegation visited Van Chan District Health Center; visited 01 private clinic specializing in obstetrics and gynecology - family planning in Tran Phu Farm Town, Van Chan District. In the afternoon of the same day, the delegation visited and participated in a communication event at Van Chan High School. Here, information and knowledge about adolescent sexual and reproductive health care was conveyed in many forms lively and interesting such as: organizing the contest "Ring the Golden Bell", painting contest... revolving around the topic of adolescent sexual and reproductive health care. The event attracted the enthusiastic participation of the teachers as well as all students at Van Chan High School.

"Improving Adolescent Sexual & Reproductive Healthcare in Yen Bai province” project launching workshop

On July 4th, 2023, in Yen Bai province, Save the Children and Daiichi Sankyo, in collaboration with the Department of Health, Pediatric and Obstetrics Hospital of Yen Bai province, organized the “Improve Adolescent Sexual and Reproductive Health Services in Yen Bai province” project launching workshop with the participation of more than 70 delegates, including: Staff of Save the Children, Representatives of donor (Daiichi Sankyo), The Deputy Director of the Department of Health was also in attendance, Department of Education and Training, Provincial Women's Union, Yen Bai Provincial Youth Union, Department of Finance,...

The project aims to protect maternal and child health in the mountainous area of northern Vietnam where many ethnic minority groups reside. Moreover, making great efforts to improve the situation regarding Adolescent Sexual and Reproductive Healthcare Services and has encouraged people to be equipped with sexual and reproductive knowledge and skills.

DSVN and Ajinomoto Vietnam Collaboration

On December 20th, 2023, Daiichi Sankyo Vietnam Company Limited (“DSV”) and Ajinomoto Vietnam Co., Ltd., (“AVN”) signed the Memorandum of Cooperation in developing special menus for ALS patients. Through this MOU, both parties express concern about helping ALS patients have delicious meals by developing special menus for and taking care of ALS patients as a matter of mutual interest.

From the beginning of August 2023, AVN began looking for experts who could advise on necessary nutrition standards and other necessary standards for ALS patients as well as advice related to the suitable structure of menu in a day, menu frame (name of each dish), proper thickening agent. In addition, seeking expert opinions on developing detailed menus or tasting trials is one of the aspects which both parties focus on.

Opening New Office in Ha Noi

On 09 January 2024, Daiichi Sankyo Vietnam Co., Ltd. has established its new business location in Ha Noi for further expansion of business in Vietnam.

The new office aims to broaden and adding reliance to our position in the capital city and north of Vietnam. This new strength has promoted us to focus more energy on the promotion to be the medical partner of healthcare professionals and closer communications with regulatory authorities.

Operation of Long An warehouse.

Our journey toward building a high-standard pharmaceutical storage facility began in May 2021 with the construction of our air-conditioned (AC) warehouse, specifically designed to maintain storage conditions between 15-25°C. By October 2022, the facility successfully obtained the Good Storage Practices (GSP) license from the Drug Administration of Vietnam, allowing us to officially launch operations in December 2022. Located in Vinh Loc 2 Industrial Park, Long An Province, Vietnam, and covering an area of 500m², our warehouse is designed to streamline our import and export operations while ensuring the standards of Daiichi Sankyo Group and compliance with local regulations.